<DOC>
	<DOCNO>NCT00403728</DOCNO>
	<brief_summary>Beyond immunosuppressive property , ciclosporine A ( CsA ) also inhibit open mitochondrial mega-channel call permeability transition pore ( mPTP ) . Opening mPTP play key role cardiomyocyte death reperfusion follow prolonged ischemic insult . Ciclosporin A show reduce infarct size administer reperfusion experimental model . The objective present study determine whether administration CsA reperfusion patient ongoing acute myocardial infarction treat coronary angioplasty might reduce infarct size .</brief_summary>
	<brief_title>Ciclosporin A Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Male female patient , age 18 , suspect first acute myocardial infarction Within 12 hour onset chest pain With need emergency revascularization angioplasty . Patients must display fully occlude ( TIMI zero flow ) culprit coronary artery , absence visible collateral exhibit TIMI flow &gt; 2 direct stenting angioplasty . Hypersensibility ciclosporine A Cardiac arrest cardiogenic shock Immunosuppressive disease ( &lt; 6 month ) : cancer , lymphoma , positive serology HIV , hepatitis , etc . Known renal failure serum creatinine &gt; 120 Âµmole/l admission Liver failure Uncontrolled hypertension Current pregnancy woman without contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Ischemia</keyword>
	<keyword>Reperfusion</keyword>
	<keyword>Myocardial infarction</keyword>
	<keyword>ciclosporin A</keyword>
	<keyword>acute myocardial infarction</keyword>
</DOC>